ciprofibrate has been researched along with Disease Exacerbation in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study of the hypolipidemic efficiency, safety and tolerance of ciprofibrate (lipanor) in therapy of atherogenic hyperlipoproteinemia." | 5.08 | [Lipanor treatment of atherogenic hyperlipoproteinemia]. ( Arabidze, GG; Kukharchuk, VV; Susekov, AV; Tvorogova, MG, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Susekov, AV | 1 |
| Tvorogova, MG | 1 |
| Arabidze, GG | 1 |
| Kukharchuk, VV | 1 |
1 trial available for ciprofibrate and Disease Exacerbation
| Article | Year |
|---|---|
[Lipanor treatment of atherogenic hyperlipoproteinemia].
Topics: Cholesterol; Clofibric Acid; Coronary Artery Disease; Disease Progression; Drug Administration Sched | 1998 |